| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/12/2013 | CN103153325A Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof |
| 06/12/2013 | CN103153301A Methods of treatment |
| 06/12/2013 | CN103153289A Improved enteric active substance delivery |
| 06/12/2013 | CN103153095A Nutritional products having improved organoleptic properties |
| 06/12/2013 | CN103146734A Anti-burn and scald infection multiple organ failure Pseudomonas aeruginosa toxin vaccine |
| 06/12/2013 | CN103146668A Preparation technology of lumbrukinase dry powder |
| 06/12/2013 | CN103146666A Streptococcus suis cell wall hydrolase as well as coding gene and application thereof |
| 06/12/2013 | CN103146631A Genetically engineered bacterium for expressing solubility pig gamma-interferonPoIFN-gamma and construction method and application of genetically engineered bacterium |
| 06/12/2013 | CN103145855A Matrix metallo-proteinase inhibitor polypeptide and application thereof |
| 06/12/2013 | CN103145851A Recombinant protein PACAP38-NtA, and coding gene and application thereof |
| 06/12/2013 | CN103145847A Anti-CD20 antibody-monomethyl auristatin E conjugate, its preparation method and application |
| 06/12/2013 | CN103145833A Urechis unicinctus hemoglobin, isolation and purification thereof and application |
| 06/12/2013 | CN103145826A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 06/12/2013 | CN103145822A Fish natural killer (NK)-lysin effective factors and application method thereof |
| 06/12/2013 | CN103145803A Polypeptide in specific binding with breast cancer brain metastases cells |
| 06/12/2013 | CN103145800A Centipede zymolyte anti-thrombus polypeptide |
| 06/12/2013 | CN103145797A [(3s)-1,2,3,4-tetrahydroisoquinoline-3-formoxy]-Lys modified RGD tetrapeptide and its synthesis method and use in medical science |
| 06/12/2013 | CN103145715A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| 06/12/2013 | CN103145608A Anti-enterovirus 71 (EV71) caprolactam compounds, and preparation method and application thereof |
| 06/12/2013 | CN103143028A Sulfhydrylated amphipathic chitosan polymer carrier as well as preparation method and application thereof |
| 06/12/2013 | CN103143024A Implantable kidney-tonifying bone-invigorating traditional Chinese medicine extract-antibiotic-calcium sulfate sustained-release system, and preparation method and application thereof |
| 06/12/2013 | CN103143022A Ophthalmologic irrigation solutions and method |
| 06/12/2013 | CN103143020A Pharmaceutical composition for treating hypertensive left ventricular hypertrophy and application thereof |
| 06/12/2013 | CN103143017A VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/12/2013 | CN103143016A Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing |
| 06/12/2013 | CN103143011A Compositions and methods for treating neurological disorders |
| 06/12/2013 | CN103143005A Application of polypeptide with LACK antigen Th2-type epitope in preparing medicine for preventing and treating autoimmune disease |
| 06/12/2013 | CN103143003A Healthcare product for relieving hangover and protecting liver |
| 06/12/2013 | CN103143002A Healthcare agent for pet bone joint and preparation method of healthcare agent |
| 06/12/2013 | CN103143001A Bone collagen high calcium tablet |
| 06/12/2013 | CN103143000A Recombinant human interferon alpha2b preparation |
| 06/12/2013 | CN103142999A Compositions and methods for treatment of microbial disorders |
| 06/12/2013 | CN103142998A Oral medical ice for preventing and treating dental ulcer and infection after chemotherapy |
| 06/12/2013 | CN103142997A Medical composition containing antifungal agent and succinate buffer liquid |
| 06/12/2013 | CN103142996A Application of endogenic marihuana peptide agonist (m) VD-Hp alpha in preparing analgesics |
| 06/12/2013 | CN103142995A Application of Anoplin in treatment of esophageal cancer |
| 06/12/2013 | CN103142994A Application of Anoplin in treatment of leukemia |
| 06/12/2013 | CN103142993A Application of Anoplin in treatment of liver cancer |
| 06/12/2013 | CN103142992A Preparation method of compound amino acid injection 15 dipeptide |
| 06/12/2013 | CN103142991A Cerebroprotein hydrolysate and lyophilized powder thereof for injection |
| 06/12/2013 | CN103142990A Medicine for treating animal bacterial diseases and preparation method thereof |
| 06/12/2013 | CN103142765A Total nutrient ganoderma lucidum snake wine containing rich selenium germanium nano elements and vitamins |
| 06/12/2013 | CN103142650A Preparation and composition of inner-alpha inhibitor protein from human plasma for treatment |
| 06/12/2013 | CN103142640A Health care product containing vitamin K2 and having functions of preventing and treating brittle-bone disease |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/12/2013 | CN103142514A Lyophilized composition for injection containing thymalfasin and preparation method thereof |
| 06/12/2013 | CN103142509A Bortezomib pharmaceutic composition for injection |
| 06/12/2013 | CN103142490A Nesiritide acetate sustained-release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103142489A Human alpha-atrial natriuretic peptide sustained release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103142488A GLP-I analogue liraglutide sustained-release microspheres and preparation method thereof |
| 06/12/2013 | CN103142475A Exenatideacetate sustained-release microsphere preparation and preparation method thereof |
| 06/12/2013 | CN103141892A Cucumber seed beverage and preparation method and application thereof |
| 06/12/2013 | CN102688181B Preparation method of medical squid-skin collagen oligopeptide gel |
| 06/12/2013 | CN102657612B GDNF-carrying microbubble preparation and method for making the same |
| 06/12/2013 | CN102580058B Therapeutic agent for blood-related disease containing epo derivative |
| 06/12/2013 | CN102372772B Ruditapes philippin RpTNF gene recombinant protein, its preparation and application |
| 06/12/2013 | CN102319425B Wound healing agent and radix astragali composite freeze-dried platelet gel kit for preparing wound healing agent |
| 06/12/2013 | CN102295694B Antimicrobial polypeptide, and preparation method and application thereof |
| 06/12/2013 | CN102271658B Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
| 06/12/2013 | CN102153641B Preparation method and application of mutain of human insulin-like growth factor binding protein 7 (IGFBP7) |
| 06/12/2013 | CN102113996B Oral formulations containing protein or peptide, and preparation method and application thereof |
| 06/12/2013 | CN102100324B Composition with strong antioxidant activity and application thereof |
| 06/12/2013 | CN101985644B Momordica charantia polypeptide, preparation method and application thereof |
| 06/12/2013 | CN101979591B Method for producing human lysozyme by using rice as bioreactor |
| 06/12/2013 | CN101918556B Cell permeable NM23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101870735B High-glycosylation erythropoietin immune fusion protein |
| 06/12/2013 | CN101851287B Menopausal gonadotropin with high specific activity as well as preparation method and application thereof |
| 06/12/2013 | CN101801996B Optimized dengue virus entry inhibitory peptide (DN81) |
| 06/12/2013 | CN101743005B Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 06/12/2013 | CN101686673B Methods for treating neoplasia with combination of chemotherapeutic agents and radiation |
| 06/12/2013 | CN101583374B Anti-cocaine compositions and treatment |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101378775B Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 06/12/2013 | CN101094689B Treatment of obesity and related disorders |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461318 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeutics |
| 06/11/2013 | US8461315 MicroRNAs and uses thereof |
| 06/11/2013 | US8461314 Nucleic acid sequences for biosynthesis of non-MccJ25-related lariat peptides |
| 06/11/2013 | US8461313 Conjugates and compositions for cellular delivery |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461302 Using immobilized metal affinity chromatography (IMAC) to recover blood coagulation factor from cell lysate |
| 06/11/2013 | US8461300 Materials and methods for stabilizing nanoparticles in salt solutions |
| 06/11/2013 | US8461299 Peptide capable of binding to immunoglobulin |
| 06/11/2013 | US8461298 Compositions and methods for modification of biomolecules |
| 06/11/2013 | US8461297 Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases |
| 06/11/2013 | US8461188 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
| 06/11/2013 | US8461119 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 06/11/2013 | US8461118 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 06/11/2013 | US8461117 Chemical linkers and cleavable substrates and conjugates thereof |
| 06/11/2013 | US8461116 Liquid composition of factor VII polypeptides |
| 06/11/2013 | US8461115 Methods for local treatment with factor VII |
| 06/11/2013 | US8461114 Methods and compositions for modulating ErbB2 activity |
| 06/11/2013 | US8461113 Elastin digest compositions and methods utilizing same |
| 06/11/2013 | US8461112 HGF preparation |
| 06/11/2013 | US8461111 Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| 06/11/2013 | US8461110 Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders |
| 06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
| 06/11/2013 | US8461108 Subdermal tissue remodeling using myostatin, methods and related systems |
| 06/11/2013 | US8461107 HCV NS3 protease inhibitors |